INTERNATIONAL PATENT: ASTERO BIOPHARMA LLC FILES APPLICATION FOR "APPROACHES FOR THE SELECTIVE DEPLETION OF ADAMTS13-SPECIFIC ANTIBODIES"

GENEVA, March 31 -- ASTERO BIOPHARMA LLC (8405 Spring CreekCollege Station, TX 77845) filed a patent application (PCT/US2025/047121) for "APPROACHES FOR THE SELECTIVE DEPLETION OF ADAMTS13-SPECIFIC ANTIBODIES" on Sep 19, 2025. With publication no. WO/2026/064598, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WARD OBER, Elizabeth, Sally (8405 Spring CreekCollege Station, TX 77845)

Abstract: The present disclosure includes a fusion protein or molecule, called a "Macromolecule that depletes ADAMTS13-specific antibodies'; ...